ProfileGDS4718 / 206955_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 73% 80% 69% 76% 74% 62% 66% 79% 85% 76% 70% 82% 71% 62% 63% 72% 77% 64% 67% 64% 72% 74% 78% 73% 72% 64% 79% 65% 83% 70% 70% 65% 84% 79% 66% 62% 69% 77% 78% 67% 80% 69% 68% 60% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1358973
GSM549102patient 115, normal, homogenized [OPG study]7.7455480
GSM549104patient 119, normal, homogenized [OPG study]6.8166369
GSM549108patient 138, normal, homogenized [OPG study]7.35976
GSM549119patient 077, normal, homogenized [OPG study]7.1439474
GSM549133patient 032, cancer, homogenized [OPG study]6.2363762
GSM549139patient 042, cancer, homogenized [OPG study]6.5573766
GSM549099patient 107, normal, homogenized [OPG study]7.6675479
GSM549109patient 139, normal, homogenized [OPG study]8.4892985
GSM549110patient 046, normal, homogenized [OPG study]7.3971376
GSM549114patient 063, normal, homogenized [OPG study]6.8431870
GSM549122patient 082, normal, homogenized [OPG study]8.050382
GSM549134patient 033, cancer, homogenized [OPG study]7.003671
GSM549136patient 036, cancer, homogenized [OPG study]6.2115962
GSM549140patient 044, cancer, homogenized [OPG study]6.3180963
GSM549111patient 047, normal, homogenized [OPG study]7.0723772
GSM549113patient 057, normal, homogenized [OPG study]7.6267577
GSM549132patient 031, cancer, homogenized [OPG study]6.4258564
GSM549137patient 038, cancer, homogenized [OPG study]6.6814967
GSM549142patient 047, cancer, homogenized [OPG study]6.4564964
GSM549100patient 110, normal, homogenized [OPG study]6.9821872
GSM549107patient 135, normal, homogenized [OPG study]7.2391374
GSM549115patient 068, normal, homogenized [OPG study]7.679778
GSM549116patient 072, normal, homogenized [OPG study]7.1807673
GSM549120patient 078, normal, homogenized [OPG study]7.0117672
GSM549131patient 030, cancer, homogenized [OPG study]6.3857864
GSM549118patient 074, normal, homogenized [OPG study]7.7375279
GSM549129patient 027, cancer, homogenized [OPG study]6.5356565
GSM549123patient 088, normal, homogenized [OPG study]8.1725683
GSM549124patient 006, cancer, homogenized [OPG study]6.8506670
GSM549126patient 015, cancer, homogenized [OPG study]6.8847270
GSM549128patient 025, cancer, homogenized [OPG study]6.5477165
GSM549103patient 117, normal, homogenized [OPG study]8.1314684
GSM549117patient 073, normal, homogenized [OPG study]7.7585879
GSM549138patient 041, cancer, homogenized [OPG study]6.5825566
GSM549141patient 045, cancer, homogenized [OPG study]6.3080362
GSM549130patient 028, cancer, homogenized [OPG study]6.7701469
GSM549101patient 111, normal, homogenized [OPG study]7.5611777
GSM549105patient 128, normal, homogenized [OPG study]7.6442378
GSM549106patient 134, normal, homogenized [OPG study]6.6358167
GSM549112patient 048, normal, homogenized [OPG study]7.9235880
GSM549125patient 011, cancer, homogenized [OPG study]6.7412569
GSM549127patient 024, cancer, homogenized [OPG study]6.8334468
GSM549135patient 035, cancer, homogenized [OPG study]6.138160